Navigation Links
Research and Development Trend of China Independent Clinical Laboratory Market, 2013-2017
Date:12/4/2013

London (PRWEB) December 04, 2013

Independent clinical laboratory industry has experienced less than 20 years’ development in China, but there were more than 110 independent clinical laboratories in China with rapid development. Kingmed, Adicon and Dian placed on the top three respectively among large-scale chain-store clinical laboratories. Market scale was approximately CNY 2.5 billion in 2012, only accounting for about 1.5% of market shares in clinical laboratory industry currently. But in America, independent clinical laboratory industry accounted for one third of market shares, so there is still a big gap when compared with America. Huidian Research takes a view that sales value of Kingmed firstly broke through CNY 1 billion as of 2012, which can be deemed as China independent clinical laboratory industry entered rapid-growth period.

Under the background of new medical reform, independent clinical laboratory industry will further expand so as to enter rapid-growth period. During this period, increasing new entrants will step into this industry, chain enterprises and solo independent laboratory will coexist. But in the long run, chain enterprises are equipped with the capacities of large-scale purchase and standard management and administration for reducing production costs; service network layout will obtain brand effect for attracting customers. However, the service of solo independent laboratory is limited within 400 kilometers, customer resources are inclined to be saturated. In addition, it will drop out the market along with losses because of declined prices. Thus chain enterprises are expected to be still prosperous.

Through comparing testing project reserves, layout of service network station and management and administration capability in domestic chain enterprises, Huidian Research holds a view of Kingmed owns absolute competitive advantages and will keep its leading position in industry due to high-end project reserves and many laboratories are widely distributed; Adicon and Dian placed on the second, Adicon has high-end project reserves and strict quality control standards, while Dian owns differentiation competitive advantages such as level-to-level administration laboratories, increase output and “ agency + service ” mode for reducing purchasing costs etc.; DAAN Gene started late (2007), so it is slightly inferior to the other three enterprises.

“Research and Development Trend of China Independent Clinical Laboratory Market, 2013-2017” mainly conducts an in-depth market research on development environment and market status quo of China independent clinical laboratory industry, makes an analysis of domestic market status quo, supply and demand, upstream and downstream industries and business performance of key enterprises, meanwhile makes a forecast for the industry so as to provide a decision-making reference for enterprises to understand and invest such industry.

Table of Contents

1. Overview of Independent Clinical Laboratory
1.1 Definition
1.2 Business Pattern
1.3 Technological Level and Technical Characteristics

2. Development History of Independent Clinical Laboratory Industry
2.1 Development Status Quo of Foreign Independent Clinical Laboratory
2.1.1 Background
2.1.2 Development of American Independent Clinical Laboratory
2.2 Development of China’s Independent Clinical Laboratory

3. Development Environment of Independent Clinical Laboratory
3.1 Cost Control in Public Hospital
3.2 Increased Treatments in Basic Medical Institutions
3.3 Rapid Development of Private Hospitals
3.4 Industry Supervision System
3.5 Policies and Major Regulations

4. Development of China Independent Clinical Laboratory Industry
4.1 Status Quo of China Independent Clinical Laboratory Market
4.1.1 Market Capacity
4.1.2 Competitive Landscape
4.1.3 Marketization Degree
4.1.4 Changing Trend of Profit and Reasons
4.1.5 Michael Porter’s Five Forces Model
4.2 Market Supply and Demand of China Independent Clinical Laboratory and Influencing Factors
4.3 Upstream Industry and Downstream Industry
4.3.1 Upstream Industry’s Impact on Independent Clinical Laboratory Industry
4.3.2 Downstream Industry’s Impact on Independent Clinical Laboratory Industry
4.4 Barriers to Entry
4.4.1 Barrier of Access
4.4.2 Quality Control
4.4.3 Technical Barrier
4.4.4 Professional Talents
4.5 Development Factors
4.5.1 Favorable Factors
4.5.2 Negative Factors

5. Key Enterprises of China Independent Clinical Laboratory
5.1 Kingmed Diagnostics
5.1.1 Company Profile
5.1.2 Service Network
5.1.3 Business Performance
5.1.4 Management and Administration Mode
5.1.5 Future Development Strategy
5.2 Dian Diagnostics
5.2.1 Company Profile
5.2.2 Business Performance
5.2.3 Business Composition Analysis
5.2.4 Major Suppliers
5.2.5 Competitive Advantages
5.2.6 Future Development Strategy and Business Plan in 2013
5.3 DAAN Gene Co., Ltd.
5.3.1 Company Profile
5.3.2 Business Performance
5.3.3 Revenue Composition
5.3.4 Suppliers
5.3.5 Competitive Advantages
5.4 Adicon
5.4.1 Company Profile
5.4.2 Business Performance
5.4.3 Future Development Strategy

6. Future Development of China Independent Clinical Laboratory
6.1 Future Development Trend
6.1.1 “12th Five-Year” Plan New Medical Reform Policy Brings Opportunities
6.1.2 Continuous Rapid Growth of Medical Service Industry Promote Independent Clinical Laboratory Service Industry
6.1.3 New Diagnostic Techniques Motive Independent Clinical Laboratory Service Industry
6.2 Challenges and Opportunities
6.3 More Market Shares and Structure Upgrade

Companies Mentioned

Kingmed Diagnostics
Dian Diagnostics
DAAN Gene Co., Ltd.
Adicon

Read the full report:

Research and Development Trend of China Independent Clinical Laboratory Market, 2013-2017

http://www.reportbuyer.com/pharma_healthcare/diagnostics/research_development_trend_china_independent_clinical_laboratory_market_2013_2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com

Read the full story at http://www.prweb.com/releases/2013/12/prweb11393048.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: